Search

This report presents an analysis of COVID-19 vaccine effectiveness (VE) after a fourth dose in relation to SARS-CoV-2 infection and severe outcomes due to the omicron variant among persons aged 65 years and older in Sweden.

Together with the public health authorities in the Nordic countries including Åland, the Faroe Islands and Greenland, the authority has gathered knowledge and experience from working with the pandemic. The report will be an important basis for continued updates of pandemic plans and for increased

Swedres-Svarm 2019 shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals. The report is a co-production between the Public Health Agency of Sweden the National Veterinary Institute (SVA).

This report is a compilation of existing knowledge about the harmful effects of tobacco and nicotine products in terms of the extent of their use, the health risks and the social costs.

This report describes the monitoring systems for influenza in use during the winter season of 2021–2022 and the results of both epidemiological and virological surveillance. Data are also compared to previous influenza seasons.

This health economic report presents a cost effectiveness analysis of introducing chickenpox vaccination for children in Sweden from a societal and healthcare perspective. It also includes analyses of costs and cost-savings at national and regional levels.

Swedres-Svarm 2014 shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals. The report is a co-production between the Public Health Agency of Sweden the National Veterinary Institute (SVA).

This report describes the monitoring systems for influenza in use during the winter season of 2020–2021 and the results of both epidemiological and virological surveillance. Data are also compared to previous influenza seasons.

Swedres-Svarm 2015 shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals. The report is a co-production between the Public Health Agency of Sweden the National Veterinary Institute (SVA).

This report describes a health economic evaluation that investigates the potential cost-effectiveness of an extension of the national vaccination programme for children against human papilloma virus to also include boys. Today, only girls are offered vaccination within the national vaccination